Bderlo 150mg Tablet is an anticancer medicine containing the active constituent erlotinib. It treats non-small lung cancer (NSCLC) and pancreatic cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. It is usually given in combination with other anticancer medicine, gemcitabine, for patients with metastatic or advanced pancreatic cancers. Patients need to inform the doctor about the use of contact lenses, any intolerance to sugars, history of eye problems, clotting disorders, or if you take medicines for clotting disorders or cholesterol. Bderlo 150mg Tablet is not recommended for adolescents and children under the age of 18. Do not take this medication with food. Use effective birth control during the treatment and for at least 2 weeks after the last dose. Patients are advised not to smoke while being treated with Bderlo 150mg Tablet, as smoking may decrease the amount of medicine in the blood. Wear protective clothing and sunscreen while going outside. Inform the physician if patients develop pain in the eye, blurred vision, cough, fever, shortness of breath, severe abdominal pain, and persistent diarrhea while taking this medicine.